Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $2.49 Million - $2.71 Million
-40,241 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $1.05 Million - $1.18 Million
17,692 Added 78.46%
40,241 $2.54 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $888,156 - $1.01 Million
15,382 Added 214.62%
22,549 $1.4 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $3.34 Million - $3.7 Million
-58,206 Reduced 89.04%
7,167 $432,000
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $196,255 - $229,442
-3,580 Reduced 5.19%
65,373 $3.84 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $2.15 Million - $3.12 Million
-46,300 Reduced 40.17%
68,953 $3.84 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $455,635 - $594,335
-9,259 Reduced 7.44%
115,253 $7.4 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $150,208 - $178,093
3,512 Added 2.9%
124,512 $6.31 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $761,217 - $841,740
-17,060 Reduced 12.36%
121,000 $5.49 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $6.23 Million - $7.43 Million
138,060 New
138,060 $6.59 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $7.25 Million - $9.4 Million
-148,610 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $8.2 Million - $9.25 Million
148,610 New
148,610 $9.23 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.